The success of the mRNA vaccines for COVID-19 led to explosive growth in lipid nanoparticle (LNP)-mediated drug delivery for RNA vaccines and therapeutics. As these projects scale into clinical trials ...

The track by which API manufacturing processes are prepared for commercial use is comparable to overlapping integrative process evaluations at commercial scale. This ensures the process is ...

The biopharmaceutical industry is expanding rapidly, driven by an increasing demand for complex biomedicines. Today, manufacturing biomolecules presents unique challenges, like cost pressure and ...

Viral vectors are engineered viruses used to deliver gene therapies, gene-modified cell therapies—such as Kite’s CAR-Ts Yescarta and Tecartus—as well as certain ...

Pascal Touchon serves as global strategy advisor to RoslinCT and board director, bringing over four decades of international experience in the biopharmaceutical industry, combining operational ...

It's an exciting time to be in cell therapy manufacturing and commercialization, particularly in the oncology space. This year alone, we've seen the US approval of three cell therapy products: Iovance ...

Intel has started early production of its 18A-P chip manufacturing process. This new technology offers better speed and power efficiency. Chips made with 18A-P will run cooler. Existing chip designs ...

TEPHRA™ platform selected to support next-generation photonic device production, further expanding Forge Nano's presence in ...

The two companies have announced an agreement to collaboratively explore technical and process opportunities to optimise commercial production of TRISO nuclear fuel to supply Kairos Power's advanced ...